Cargando…

Analysis of plasma metabolic profile, characteristics and enzymes in the progression from chronic hepatitis B to hepatocellular carcinoma

Hepatitis B virus (HBV) infection is an important factor causing hepatocellular carcinoma (HCC). The aim of this study was to investigate the metabolic characteristics and related metabolic enzyme changes during the progression from chronic hepatitis B (CHB) to liver cirrhosis (LC) and, ultimately,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Fei-Fei, Song, Ya-Nan, Lu, Yi-Yu, Zhang, Yongyu, Hu, Yi-Yang, Su, Shi-Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425494/ https://www.ncbi.nlm.nih.gov/pubmed/32701483 http://dx.doi.org/10.18632/aging.103554

Ejemplares similares

Serum cytokine profiling analysis for zheng differentiation in chronic hepatitis B
por: Lu, Yi-Yu, et al.
Publicado: (2015)

Metabolic profiling of hepatitis B virus-related hepatocellular carcinoma with diverse differentiation grades
por: Zhang, Lei, et al.
Publicado: (2017)

Hepatic Enzyme Profile in Horses
por: Satué, Katy, et al.
Publicado: (2022)

Progression from Excessive to Deficient Syndromes in Chronic Hepatitis B: A Dynamical Network Analysis of miRNA Array Data
por: Chen, Qi-Long, et al.
Publicado: (2013)

Research Progress of DUB Enzyme in Hepatocellular Carcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

Profiling of plasma metabolomics in patients with hepatitis C-related liver cirrhosis and hepatocellular carcinoma
por: Nomair, Azhar Mohamed, et al.
Publicado: (2019)

Plasma Metabolomics Reveals Metabolic Profiling For Diabetic Retinopathy and Disease Progression
por: Sun, Yu, et al.
Publicado: (2021)

Association between Dietary Patterns and Serum Hepatic Enzyme Levels in Adults with Dyslipidemia and Impaired Fasting Plasma Glucose
por: Lin, Li-Yin, et al.
Publicado: (2021)

Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma
por: Wang, Pei-Wen, et al.
Publicado: (2022)

CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity
por: Dong, Zhao-Ru, et al.
Publicado: (2021)

A non-synonymous polymorphism in NBS1 is associated with progression from chronic hepatitis B virus infection to hepatocellular carcinoma in a Chinese population
por: Zhen, Ya’nan, et al.
Publicado: (2018)

Classification of Traditional Chinese Medicine Syndromes in Patients with Chronic Hepatitis B by SELDI-Based ProteinChip Analysis
por: Song, Ya-Nan, et al.
Publicado: (2012)

Plasma Metabolic Profiles in Women are Menopause Dependent
por: Ke, Chaofu, et al.
Publicado: (2015)

Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma
por: Sun, Ruonan, et al.
Publicado: (2023)

Bioinformatics Analysis Identifies ASCL1 as the Key Transcription Factor in Hepatocellular Carcinoma Progression
por: Zhang, Hong-yan, et al.
Publicado: (2023)

Metabolic characterization of the natural progression of chronic hepatitis B
por: Schoeman, Johannes C., et al.
Publicado: (2016)

The serum metabolic profiles of different Barcelona stages hepatocellular carcinoma associated with hepatitis B virus
por: Zhang, Lei, et al.
Publicado: (2018)

Primary hepatic paraganglioma mimicking hepatocellular carcinoma: a case report
por: Li, Li, et al.
Publicado: (2022)

Covariation Analysis of Serumal and Urinary Metabolites Suggests Aberrant Glycine and Fatty Acid Metabolism in Chronic Hepatitis B
por: Yang, Linlin, et al.
Publicado: (2016)

Clinicopathologic characteristics and outcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection
por: Aljumah, Abdulrahman A., et al.
Publicado: (2018)

Malic enzyme 2 promotes the progression of hepatocellular carcinoma via increasing triglyceride production
por: Zhang, Shuai, et al.
Publicado: (2021)

Identification of Endogenous Controls for Analyzing Serum Exosomal miRNA in Patients with Hepatitis B or Hepatocellular Carcinoma
por: Li, Yi, et al.
Publicado: (2015)

Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B
por: Yu, Ming-Whei, et al.
Publicado: (2022)

Role of Hepatic and Intestinal P450 Enzymes in the Metabolic Activation of the Colon Carcinogen Azoxymethane in Mice
por: Megaraj, Vandana, et al.
Publicado: (2014)

Prediction of hepatic necroinflammatory activity in patients with chronic hepatitis B by a simple noninvasive model
por: Shen, Fei-Fei, et al.
Publicado: (2018)

Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway
por: Cai, Fei-Fei, et al.
Publicado: (2018)

Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics
por: Diamond, Deborah L., et al.
Publicado: (2010)

Impaired plasma lipid profiles in acute hepatitis
por: Luo, Libo, et al.
Publicado: (2010)

The change of plasma metabolic profile and gut microbiome dysbiosis in patients with rheumatoid arthritis
por: Zhu, Jing, et al.
Publicado: (2022)

Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma
por: Sangineto, Moris, et al.
Publicado: (2020)

Characteristics of lactate metabolism phenotype in hepatocellular carcinoma
por: Zhang, Jiacheng, et al.
Publicado: (2023)

Transmembrane protein 88 suppresses hepatocellular carcinoma progression and serves as a novel prognostic factor
por: Cai, Lin, et al.
Publicado: (2023)

Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer
por: Cao, Lin-Lin, et al.
Publicado: (2022)

Retracted Article: MicroRNA-1271 modulates hepatitis B virus replication, cell proliferation and apoptosis in hepatitis B virus-related hepatocellular carcinoma by targeting SIRT1
por: Tang, Fei, et al.
Publicado: (2019)

Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma
por: Xu, Fei-Qi, et al.
Publicado: (2023)

A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma
por: Hu, Hui, et al.
Publicado: (2022)

Frequent alteration of the protein synthesis of enzymes for glucose metabolism in hepatocellular carcinomas
por: Shimizu, Takayuki, et al.
Publicado: (2013)

Circular RNAs: Characteristics, Function and Clinical Significance in Hepatocellular Carcinoma
por: Wang, Man, et al.
Publicado: (2018)

New LncRNAs in Chronic Hepatitis C progression: from fibrosis to hepatocellular carcinoma
por: Ferrasi, Adriana Camargo, et al.
Publicado: (2020)

METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
por: Wei, Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hvtc9k38erbgq5q5ck9n1ul5q9